Latest Healthcare Policy news from across the web.
The Broad Institute, Boston Children’s Hospital, and Maine’s Jackson Laboratory announced a collaboration to develop rare disease gene therapies.
Read full article →Novo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The Readout
Read full article →Novo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effective
Read full article →Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly competitive market.
Read full article →Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to make its obesity and diabetes drugs appear more effective.
Read full article →The latest on cyclospora, THC sodas at the grocery store, and more health news from Morning Rounds
Read full article →A coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs aimed at lowering Medicare drug costs.
Read full article →“Post-pandemic polarization threatens to lock our memories into attractive, untrue conclusions that will leave us unprotected next time,” write Marc Lipsitch and Sara Cody.
Read full article →The proposed rule could “weaken the NIH’s benign influence over research risks,” writes Doni Bloomfield.
Read full article →Only about 1 in 8 nurses are men, but their share is growing. A strong job market for nurses and sustained efforts to recruit men into the field have made a difference, including in the South.
Read full article →The FDA retracted its only positive test for cyclospora, the parasite at the center of a multistate outbreak, on Taylor Farms lettuce. But the agency believes lettuce from the brand is still linked.
Read full article →Under the Trump administration, dozens of advisory committees have been ended or frozen, including one on controlling infection in healthcare settings.
Read full article →